Denali Therapeutics, Inc. (DNLI)
20.71
-0.97
(-4.47%)
USD |
NASDAQ |
Apr 16, 16:00
20.86
+0.15
(+0.72%)
After-Hours: 04:53
Denali Therapeutics Free Cash Flow : -422.10M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Neurocrine Biosciences, Inc. | 748.70M |
| Protalix Biotherapeutics, Inc. | -13.63M |
| Biogen, Inc. | 1.969B |
| Agenus, Inc. | -77.20M |
| Curis, Inc. | -27.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -98.54M |
| Cash from Investing (Quarterly) | 20.77M |
| Cash from Financing (Quarterly) | 192.13M |
| Free Cash Flow Per Share (Quarterly) | -0.5703 |
| Free Cash Flow to Equity (Quarterly) | -97.95M |
| Free Cash Flow to Firm (Quarterly) | -100.06M |
| Free Cash Flow Yield | -11.81% |